Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 441 of 5804
-
New drug combo aims to keep aggressive myeloma at bay
Disease control Recruiting nowThe purpose of the study is to evaluate the effect of Elranatamab therapy after cilta-cel measuring how long a patient with high risk relapsed myeloma lives without the myeloma getting worse(progressing), also known as progression-free survival (PFS). Patients with clinical high-…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New antibody cocktail aims to tame ulcerative colitis
Disease control Recruiting nowThis is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and …
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New vaccine combo aims to boost immune attack on pancreatic cancer
Disease control Recruiting nowThe purpose of this study is to determine the optimal dose of AGEN2373 that is safe when given in combination with balstilimab and Pancreatic GVAX Whole Cell Vaccine and evaluate the safety and clinical activity of balstilimab and AGEN2373 in combination with GVAX (Arm 1) or mKRA…
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a pill prevent eye cancer spread? new trial aims to find out
Prevention Recruiting nowThe purpose of this study is to see if giving participants quisinostat will prevent participants' uveal melanoma tumor from spreading. The researchers want to find out the effects that quisinostat has on participants' condition.
Phase: PHASE2 • Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Brain zaps for bipolar blues: new hope for Treatment-Resistant depression?
Symptom relief Recruiting nowThe purpose of this trial is to conduct an adequately powered clinical trial of once daily LFR for individuals diagnosed with treatment-resistant BD-DE who have not responded to iTBS or sham treatment applied to the left DLPFC. This work will develop the evidence supporting the u…
Phase: PHASE3 • Sponsor: Tyler Kaster • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New drug trial aims to ease muscle weakness in myasthenia gravis
Disease control Recruiting nowThe purpose of the study is to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis.
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for advanced colon cancer: AK112 combo enters phase 3 trial
Disease control Recruiting nowThis trial is a Phase III study. The purpose of this study is to evaluate the efficacy and safety of AK112 and chemotherapy versus bevacizumab and chemotherapy for the first-line treatment of metastatic colorectal cancer.
Phase: PHASE3 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Brain bleed breakthrough? new trial tests early surgery against standard care
Disease control Recruiting nowThe main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also…
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for CLL patients: a drug that may spare the heart
Disease control Recruiting nowThis phase II trial tests how well acalabrutinib works in treating patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and evaluates how treatment with acalabrutinib affects heart function. Acalabrutinib is in a class of medications called kinase inh…
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New study aims to prevent pregnancy complications with smart sugar tracking
Disease control Recruiting nowThe goal of this clinical trial is to use continuous glucose monitoring (CGM) to quickly detect and manage high blood sugar in pregnant women, early in pregnancy. The main questions it aims to answer are: (1) any problems for the baby, such as being too large for their age, shou…
Phase: NA • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Nasal spray could rapidly ease depression and suicidal urges
Symptom relief Recruiting nowThe purpose of this study is to learn about: * To evaluate the efficacy of PRT-042 nasal spray for the Rapid Reduction of the depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior * To evaluate the safety and pharmacokinetic …
Phase: PHASE2 • Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New hope for kids with tough cancers: targeted drug enters trial
Disease control Recruiting nowResearchers are looking for new ways to treat children with hepatoblastoma or rhabdomyosarcoma (RMS) that has relapsed or is refractory: * Hepatoblastoma is a common liver cancer in babies and very young children * RMS is a cancer that starts in muscle cells, often in a child's …
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Double-Barreled CAR-T attack on Hard-to-Treat myeloma
Disease control Recruiting nowThis is a multicenter, open-label, non-randomized, single-arm clinical trial. Patients with relapsed/refractory multiple myeloma accompanied by extramedullary infiltration will receive BCMA - CD19 CAR-T cell therapy. The primary objective is to prospectively evaluate the safety …
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Double-Barreled CAR-T cells take aim at Hard-to-Treat myeloma
Disease control Recruiting nowThis is a multicenter, open-label, non-randomized, single-arm clinical trial. Patients with relapsed/refractory multiple myeloma accompanied by extramedullary infiltration will receive BCMA - GPRC5D CAR-T cell therapy. The primary objective is to prospectively evaluate the safet…
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug combo aims to boost surgery success in bile duct cancer
Disease control Recruiting nowThe goal of this clinical trial is to learn if Tuvonralimab/Iparomlimab-based neoadjuvant regimens can improve surgical and pathological outcomes in adults (≥18 years) with resectable or borderline-resectable biliary tract cancer (intrahepatic/extrahepatic cholangiocarcinoma or g…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo therapy aims to slow head and neck cancer spread
Disease control Recruiting nowThis is a randomized open-label multicentre phase III superiority study of the effect of adding SABR to the standard of care treatment pembrolizumab on progression free survival in patients with oligometastases of a squamous cell carcinoma of the head and neck (SCCHN), histologic…
Phase: PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Magic mushroom therapy could help cancer survivors beat depression
Symptom relief Recruiting nowThis clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression and/or anxiety.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New hope for Hard-to-Treat colorectal cancer: experimental drug combo enters human trials
Disease control ENROLLING_BY_INVITATIONXS-03 in combination with FOLFOX or FOLFIRI and Bevacizumab for treatment of metastatic colorectal cancer patients with RAS mutation
Phase: PHASE1, PHASE2 • Sponsor: NovaOnco Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:33 UTC
-
Could taking a break from hormone therapy be just as good for prostate cancer?
Disease control Recruiting nowThis study addresses the global topic of treatment optimization, i.e. achieving similar benefit while reducing the duration of treatment, hence hoping to decrease the burden of side-effects, improve quality-of life and reduce resource utilization. The primary goal of de-escalati…
Phase: PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 26, 2026 19:20 UTC
-
Blood test may guide cancer care without biopsy
Knowledge-focused Recruiting nowctDNA stands for circulating tumour DNA. As ctDNA is released by tumour cells into the blood stream, taking a blood sample and analysing it for ctDNA, can provide a lot of useful information about a patient's cancer. In certain situations, ctDNA can be used to screen for or detec…
Phase: NA • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC